Group One Trading’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3
Closed -$1K 7946
2022
Q3
$1K Buy
+3
New +$2.61K ﹤0.01% 7366
2022
Q2
Sell
-11
Closed -$26K 8398
2022
Q1
$26K Sell
11
-20
-65% -$47.4K ﹤0.01% 6588
2021
Q4
$79K Sell
31
-192
-86% -$768K ﹤0.01% 5939
2021
Q3
$1.02M Buy
223
+125
+128% +$848K ﹤0.01% 3394
2021
Q2
$673K Sell
98
-66
-40% -$456K ﹤0.01% 3886
2021
Q1
$1.2M Buy
164
+136
+486% +$1.14M ﹤0.01% 3012
2020
Q4
$227K Buy
28
+10
+56% +$89.9K ﹤0.01% 3967
2020
Q3
$181K Buy
18
+1
+6% +$8.2K ﹤0.01% 3730
2020
Q2
$113K Buy
17
+5
+42% +$34.4K ﹤0.01% 3801
2020
Q1
$52K Sell
12
-16
-57% -$80.1K ﹤0.01% 3690
2019
Q4
$167K Buy
28
+14
+100% +$89.5K ﹤0.01% 3300
2019
Q3
$96K Buy
+14
New +$102K ﹤0.01% 3589
2019
Q2
Sell
-5
Closed -$37K 5315
2019
Q1
$37K Hold
5
﹤0.01% 3722
2018
Q4
$27K Hold
5
﹤0.01% 3884
2018
Q3
$44K Buy
+5
New +$40.7K ﹤0.01% 4042

Other funds holding RDHL

Group One Trading's RDHL Position: Q1 2026 in Review

Group One Trading sold out of Redhill Biopharma (RDHL) in Q1 2026, closing a stake of 4 shares — an estimated $4 sold.

Group One Trading first reported a position in RDHL in Q3 2018 and held it in 25 quarters. The position peaked at $403K in Q2 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2026.

  • Group One Trading reported no remaining Redhill Biopharma position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 4 Redhill Biopharma shares in Q1 2026, an estimated $4.
  • Group One Trading first reported a position in Redhill Biopharma in Q3 2018 and held it in 25 quarters.
  • Group One Trading's Redhill Biopharma position peaked at $403K in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.